(SRPT) Sarepta Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Sarepta Therapeutics | (SRPT) share price targets
Complete technical analysis of Sarepta Therapeutics (SRPT) by charts plus indicators, forecast predictions and share price targets for Sarepta Therapeutics (SRPT)
Sarepta Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Sarepta Therapeutics is 2326950
| Date | Daily Closing Price | Open | High | Low | Volume |
| 23 Thu Mar 2023 | 128.38 | 130.20 | 131.12 | 125.67 | 0.426 times |
| 22 Wed Mar 2023 | 129.11 | 131.94 | 131.94 | 128.71 | 0.721 times |
| 21 Tue Mar 2023 | 131.17 | 132.68 | 137.09 | 130.45 | 0.907 times |
| 20 Mon Mar 2023 | 131.38 | 123.89 | 131.77 | 123.30 | 1.156 times |
| 17 Fri Mar 2023 | 122.69 | 119.31 | 125.08 | 117.11 | 3.186 times |
| 16 Thu Mar 2023 | 149.67 | 145.51 | 150.81 | 143.75 | 0.833 times |
| 15 Wed Mar 2023 | 145.47 | 143.84 | 145.81 | 142.86 | 0.442 times |
| 14 Tue Mar 2023 | 144.90 | 143.81 | 148.26 | 143.73 | 0.522 times |
| 13 Mon Mar 2023 | 142.77 | 143.04 | 149.00 | 142.21 | 0.517 times |
| 10 Fri Mar 2023 | 143.92 | 148.45 | 148.50 | 141.00 | 0.78 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 127.5 as stoploss in an intra day buy trade for a target of 140. However, stock will show a bearish move below 127.5.
Share price targets for Sarepta Therapeutics (SRPT)
| Target Type | Value |
| Downside Target | 100.15 |
| Downside Target | 116.10 |
| Downside Target | 121.83 |
| Downside Target | 127.57 |
| Upside Target | 133.47 |
| Upside Target | 134.08 |
| Upside Target | 137.09 |
| Upside Target | 141.00 |
| Upside Target | 150.81 |
| Upside Target | 157.00 |
| Upside Target | 159.84 |
Intraday share price targets for Sarepta Therapeutics (SRPT)
| Target Type | Value |
| Downside Intraday Target | 122.09 |
| Downside Intraday Target | 115.8 |
| Upside Intraday Target | 135.88 |
| Upside Intraday Target | 143.38 |
| Upside Intraday Target | 129.59 |
Weekly technical analysis of Sarepta Therapeutics (SRPT)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 23 Thu Mar 2023 | 128.38 | 123.89 | 137.09 | 123.30 | 0.583 times |
| 17 Fri Mar 2023 | 122.69 | 143.04 | 150.81 | 117.11 | 1.429 times |
| 10 Fri Mar 2023 | 143.92 | 155.83 | 159.84 | 141.00 | 0.531 times |
| 03 Fri Mar 2023 | 155.61 | 123.48 | 157.00 | 117.25 | 5.256 times |
| 24 Fri Feb 2023 | 123.06 | 124.19 | 127.57 | 121.83 | 3.897 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Sarepta Therapeutics (SRPT)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 23 Thu Mar 2023 | 128.38 | 144.00 | 159.84 | 117.11 | 2.223 times |
| 28 Tue Feb 2023 | 122.13 | 125.00 | 127.57 | 116.25 | 0.93 times |
| 31 Tue Jan 2023 | 124.97 | 128.69 | 133.47 | 116.10 | 1.189 times |
| 30 Fri Dec 2022 | 129.58 | 122.57 | 134.08 | 116.91 | 0.845 times |
Scroll below to view daily charts
Price has moved up this month, and volume has increased substantially. This means that the move can continue in coming months.
Indicators analysis of Sarepta Therapeutics (SRPT)
| Indicator Name | Indicator Value | Indicator Signal |
| ADX | 26, 37, 17 | Sell |
| MACD | 2, 5 | Sell |
| Stochastics | 34 | None |
| CCI | -66 | Sell |
| RSI | 53 | Buy |
| OBV | 969900 | Sell |
| VWAP | 133 | Sell |
| ADL | 0 | Sell |
| ROC | -14 | Sell |
| Force Index | 0 | Sell |
Price action analysis of Sarepta Therapeutics ( (SRPT) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Sarepta Therapeutics ( (SRPT) ) based on a short term time period is
Price action analysis of Sarepta Therapeutics ( (SRPT) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Sarepta Therapeutics ( (SRPT) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Sarepta Therapeutics stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Sarepta Therapeutics in short term but the sell signal is initial and weak.
Sarepta Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Sarepta Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Sarepta Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 132.79 and Sarepta Therapeutics (SRPT) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Sarepta Therapeutics (SRPT) stock. Volume based technical analysis of Sarepta Therapeutics (SRPT) stock is negative.
Sarepta Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Daily charts
NSE Gainers NSE Losers BSE Gainers BSE Losers
Munafa NEWSTerms of Use Create Support ticket Your support tickets Powered by ePowerPress Stock Market News! Top Seo SMO © munafa.biz2023 All Rights reserved.